Monitoring CHO cell cultures: cell stress and early apoptosis assessment by mass spectrometry.

Mammalian cells, especially CHO (Chinese Hamster Ovary), are an important host for the production of biopharmaceuticals. Early detection of cellular stress and the onset of apoptosis, ultimately leading to a reduced viability of the culture, are important with respect to process development and monitoring. In this work, intact cell MALDI mass spectrometry (ICM MS) biotyping was used to rapidly and sensitively detect cell stress and the onset of apoptosis at line in CHO cell cultures. We describe the identification of specific and highly reproducible stress and apoptosis related changes in m/z signal intensities that allowed prediction of upcoming cell viability changes approximately 24h earlier than standard culture monitoring. Furthermore, early identification of apoptosis onset was comparable to that using a sensitive, albeit offline, detection method. By comparison with ICM MS analysis of apoptosis induced cultures, many of the m/z values were identified as apoptosis-specific. A classification model for discrimination of unknown samples regarding their cellular viability/apoptosis status was developed based on a condensed set of 51 m/z values. The fast, robust and automated acquisition of cell state specific MS signatures could become a promising tool for CHO culture monitoring.

[1]  A. Nienow.  Reactor Engineering in Large Scale Animal Cell Culture , 2006, Cytotechnology.

[2]  D. Marks,et al.  Equipment design considerations for large scale cell culture , 2003, Cytotechnology.

[3]  J. E. Dowd,et al.  On-line Measurements and Control of Viable Cell Density in Cell Culture Manufacturing Processes using Radio-frequency Impedance , 2006, Cytotechnology.

[4]  P. Wiedemann,et al.  In situ microscopic cytometry enables noninvasive viability assessment of animal cells by measuring entropy states , 2011, Biotechnology and bioengineering.

[5]  R A Knight,et al.  Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 , 2005, Cell Death and Differentiation.

[6]  Y. Lam,et al.  Rapid detection of apoptosis in mammalian cells by using intact cell MALDI mass spectrometry. , 2011, The Analyst.

[7]  Ana P. Teixeira,et al.  Advances in on-line monitoring and control of mammalian cell cultures: Supporting the PAT initiative. , 2009, Biotechnology advances.

[8]  C. Clarke,et al.  Predicting cell-specific productivity from CHO gene expression. , 2011, Journal of biotechnology.

[9]  Maike A. Laussmann,et al.  The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome. , 2012, Experimental cell research.

[10]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[11]  A S Rathore,et al.  Process analytical technology (PAT) for biopharmaceutical products: Part I. concepts and applications , 2010, Biotechnology and bioengineering.

[12]  G. Rao,et al.  Bioreactor environment‐sensitive sentinel genes as novel metrics for cell culture scale‐down comparability , 2012, Biotechnology progress.

[13]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[14]  M. Al‐Rubeai,et al.  The isolation and identification of a secreted biomarker associated with cell stress in serum‐free CHO cell culture , 2009, Biotechnology and bioengineering.

[15]  Gary Walsh,et al.  Biopharmaceutical benchmarks 2010 , 2010, Nature Biotechnology.

[16]  C. Hopf,et al.  Sensitive, robust and automated protein analysis of cell differentiation and of primary human blood cells by intact cell MALDI mass spectrometry biotyping , 2012, Analytical and Bioanalytical Chemistry.

[17]  P. Meleady,et al.  Proteomic Profiling of Secreted Proteins from CHO Cells Using Surface‐Enhanced Laser Desorption Ionization Time‐of‐Flight Mass Spectrometry , 2008, Biotechnology progress.

[18]  I. Guerrera,et al.  Application of Mass Spectrometry in Proteomics , 2005, Bioscience reports.

[19]  T G Cotter,et al.  Cell death (apoptosis) in cell culture systems. , 1995, Trends in biotechnology.

[20]  M. Al‐Rubeai,et al.  Cell death in bioreactors: A role for apoptosis , 1994, Biotechnology and bioengineering.

[21]  Florian M Wurm,et al.  Manufacturing recombinant proteins in kg-ton quantities using animal cells in bioreactors. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  M. Karas,et al.  Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. , 1988, Analytical chemistry.

[23]  Timothy J Griffin,et al.  Advancing mammalian cell culture engineering using genome-scale technologies. , 2007, Trends in biotechnology.

[24]  Lloyd M. Smith,et al.  Identification of mammalian cell lines using MALDI-TOF and LC-ESI-MS/MS mass spectrometry , 2006, Journal of the American Society for Mass Spectrometry.

[25]  F. Wurm.  Production of recombinant protein therapeutics in cultivated mammalian cells , 2004, Nature Biotechnology.

[26]  P. Demirev,et al.  Characterization of intact microorganisms by MALDI mass spectrometry. , 2001, Mass spectrometry reviews.

[27]  Niki S. C. Wong,et al.  Rapid characterization of high/low producer CHO cells using matrix-assisted laser desorption/ionization time-of-flight. , 2010, Rapid communications in mass spectrometry : RCM.

[28]  Mike Hoare,et al.  Rapid monitoring of recombinant protein products: a comparison of current technologies. , 2002, Trends in biotechnology.

[29]  M. Al‐Rubeai,et al.  Monitoring of Apoptosis , 2004 .

[30]  Wei-Shou Hu,et al.  Engineering cells for cell culture bioprocessing--physiological fundamentals. , 2006, Advances in biochemical engineering/biotechnology.

[31]  F. Wurm,et al.  25 years of recombinant proteins from reactor-grown cells - where do we go from here? , 2009, Biotechnology advances.

[32]  D. Zheng,et al.  Actinomycin D enhances TRAIL-induced caspase-dependent and -independent apoptosis in SH-SY5Y neuroblastoma cells , 2007, Neuroscience Research.

[33]  Katharina D'Herde,et al.  Apoptosis and necrosis: detection, discrimination and phagocytosis. , 2008, Methods.

[34]  L. Zitvogel,et al.  Cell death modalities: classification and pathophysiological implications , 2007, Cell Death and Differentiation.

[35]  M. Welker.  Proteomics for routine identification of microorganisms , 2011, Proteomics.

[36]  M. Al‐Rubeai,et al.  The application of SELDI-TOF mass spectrometry to mammalian cell culture. , 2009, Biotechnology advances.

[37]  R A Knight,et al.  Classification of cell death: recommendations of the Nomenclature Committee on Cell Death , 2005, Cell Death and Differentiation.

[38]  S. Korsmeyer,et al.  Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.

[39]  Lucia Baldi,et al.  Recombinant therapeutic protein production in cultivated mammalian cells: current status and future prospects. , 2008, Drug discovery today. Technologies.